Phibro Animal Health Corp SEC filings PAHC

Phibro Animal Health Corp has 774 filings in SEC EDGAR's recent list, going back to Sep 29, 1998. Its latest annual report, Form ARS, was filed on Sep 18, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, shareholder vote results). The company's fiscal year ends on June 30.

Phibro Animal Health Corp SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Shareholder vote results
Nov 4, 2026 Nov 3, 2026
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Other events
Nov 3, 2026 Nov 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 19, 2026 —
ARS Annual report to shareholders Sep 18, 2026 Jun 30, 2026
DEFA14A Additional proxy material Sep 18, 2026 —
DEF 14A Proxy statement Sep 18, 2026 Nov 3, 2026
4/A Ownership document Sep 17, 2026 Aug 6, 2026
4/A Ownership document Sep 17, 2026 Aug 6, 2026
144 Notice of proposed sale Sep 16, 2026 —
8-K Current report
Results of operations
Aug 26, 2026 Aug 26, 2026
10-K Annual report Aug 26, 2026 Jun 30, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 30, 2026 —
8-K Current report
Other events
Jul 28, 2026 Jul 28, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
8-K Current report
Officer or director change
Jun 26, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 16, 2026 —
4 Insider transaction Jun 2, 2026 May 29, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 22, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
4 Insider transaction May 7, 2026 May 5, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Other events
May 5, 2026 May 5, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
8-K Current report
Material agreement, New debt
Apr 30, 2026 Apr 28, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
8-K Current report
Regulation FD disclosure
Apr 27, 2026 Apr 27, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 23, 2026 —
4 Insider transaction Apr 23, 2026 Apr 21, 2026
4 Insider transaction Apr 16, 2026 Apr 14, 2026
8-K Current report
Officer or director change
Apr 14, 2026 Apr 13, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 7, 2026 —
4 Insider transaction Mar 31, 2026 Mar 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
144 Notice of proposed sale Mar 13, 2026 —
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 23, 2026 Feb 19, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 11, 2026 Feb 10, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
144 Notice of proposed sale Feb 11, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 11, 2026 —
4 Insider transaction Feb 9, 2026 Feb 5, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
8-K Current report
Results of operations
Feb 4, 2026 Feb 4, 2026
10-Q Quarterly report Feb 4, 2026 Dec 31, 2025
8-K Current report
Other events
Feb 3, 2026 Feb 3, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Jan 27, 2026 Jan 23, 2026
4 Insider transaction Jan 22, 2026 Jan 21, 2026
3 Initial insider ownership Jan 22, 2026 Jan 12, 2026
4 Insider transaction Jan 15, 2026 Jan 13, 2026
4 Insider transaction Jan 13, 2026 Jan 9, 2026
4 Insider transaction Jan 8, 2026 Jan 7, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 18, 2025 Dec 16, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 15, 2025 —
4 Insider transaction Dec 15, 2025 Dec 11, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 4, 2025 Dec 3, 2025
144 Notice of proposed sale Dec 4, 2025 —
4 Insider transaction Dec 2, 2025 Nov 28, 2025
4 Insider transaction Nov 26, 2025 Nov 25, 2025
4 Insider transaction Nov 24, 2025 Nov 20, 2025
4 Insider transaction Nov 18, 2025 Nov 14, 2025
4 Insider transaction Nov 13, 2025 Nov 11, 2025
4 Insider transaction Nov 10, 2025 Nov 7, 2025
4 Insider transaction Nov 6, 2025 Nov 4, 2025
8-K Current report
Results of operations, Shareholder vote results
Nov 5, 2025 Nov 4, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Other events
Nov 4, 2025 Nov 4, 2025
4 Insider transaction Oct 30, 2025 Oct 28, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
4 Insider transaction Oct 21, 2025 Oct 17, 2025
4 Insider transaction Oct 1, 2025 Sep 30, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
ARS Annual report to shareholders Sep 19, 2025 Jun 30, 2025
DEFA14A Additional proxy material Sep 19, 2025 —
DEF 14A Proxy statement Sep 19, 2025 Nov 4, 2025
4 Insider transaction Sep 11, 2025 Sep 9, 2025
144 Notice of proposed sale Sep 4, 2025 —
8-K Current report
Results of operations
Aug 27, 2025 Aug 27, 2025
10-K Annual report Aug 27, 2025 Jun 30, 2025
144 Notice of proposed sale Aug 19, 2025 —
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
8-K Current report
Other events
Jul 29, 2025 Jul 29, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 3, 2025 —
144 Notice of proposed sale May 19, 2025 —
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Other events
May 6, 2025 May 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 28, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 28, 2025 —
4 Insider transaction Feb 26, 2025 Feb 24, 2025
144 Notice of proposed sale Feb 18, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 11, 2025 Feb 9, 2025
8-K Current report
Results of operations
Feb 5, 2025 Feb 5, 2025
10-Q Quarterly report Feb 5, 2025 Dec 31, 2024
8-K Current report
Other events
Feb 4, 2025 Feb 4, 2025
3 Initial insider ownership Jan 28, 2025 Jan 21, 2025
8-K Current report
Officer or director change
Jan 23, 2025 Jan 21, 2025
8-K/A Amended current report Jan 7, 2025 Oct 31, 2024
SC 13D/A Amended ownership over 5% (active) Nov 15, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Officer or director change
Nov 12, 2024 Nov 7, 2024
8-K Current report
Results of operations, Shareholder vote results
Nov 6, 2024 Nov 5, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Other events
Nov 5, 2024 Nov 5, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
8-K Current report
Acquisition or sale of assets, New debt, Regulation FD disclosure
Oct 31, 2024 Oct 31, 2024
SCHEDULE 13G Ownership over 5% (passive) Oct 16, 2024 —
ARS Annual report to shareholders Sep 20, 2024 Jun 30, 2024
DEFA14A Additional proxy material Sep 20, 2024 —
DEF 14A Proxy statement Sep 20, 2024 Nov 5, 2024
4 Insider transaction Sep 6, 2024 Sep 4, 2024
8-K Current report
Results of operations
Aug 28, 2024 Aug 28, 2024
10-K Annual report Aug 28, 2024 Jun 30, 2024
144 Notice of proposed sale Aug 13, 2024 —
8-K Current report
Other events
Jul 30, 2024 Jul 30, 2024
8-K Current report
Material agreement, New debt
Jul 9, 2024 Jul 9, 2024
144 Notice of proposed sale May 13, 2024 —
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Other events
May 7, 2024 May 7, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Apr 29, 2024 Apr 28, 2024
144 Notice of proposed sale Mar 5, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 9, 2024 Feb 9, 2024
3 Initial insider ownership Feb 9, 2024 Feb 9, 2024
SC 13G Ownership over 5% (passive) Feb 8, 2024 —
8-K Current report
Results of operations
Feb 7, 2024 Feb 7, 2024
10-Q Quarterly report Feb 7, 2024 Dec 31, 2023
8-K Current report
Other events
Feb 6, 2024 Feb 6, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 6, 2024 Feb 6, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 19, 2024 —
SC 13G Ownership over 5% (passive) Jan 10, 2024 —
SC 13G Ownership over 5% (passive) Dec 8, 2023 —
144 Notice of proposed sale Dec 5, 2023 —
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Shareholder vote results
Nov 7, 2023 Nov 6, 2023
8-K Current report
Regulation FD disclosure
Nov 7, 2023 Nov 7, 2023
8-K Current report
Other events
Nov 6, 2023 Nov 6, 2023
ARS Annual report to shareholders Sep 15, 2023 Jun 30, 2023
DEFA14A Additional proxy material Sep 15, 2023 —
DEF 14A Proxy statement Sep 15, 2023 Nov 6, 2023
144 Notice of proposed sale Sep 5, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 5, 2023 Sep 5, 2023
8-K Current report
Results of operations
Aug 30, 2023 Aug 30, 2023
10-K Annual report Aug 30, 2023 Jun 30, 2023
8-K Current report
Other events
Jul 25, 2023 Jul 25, 2023
3 Initial insider ownership Jul 7, 2023 Jul 1, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
8-K Current report
Officer or director change
Jul 6, 2023 Jul 5, 2023
8-K Current report
Material agreement, New debt
Jun 16, 2023 Jun 16, 2023
SC 13D/A Amended ownership over 5% (active) Jun 8, 2023 —
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
10-Q Quarterly report May 3, 2023 Mar 31, 2023
8-K Current report
Other events
May 1, 2023 May 1, 2023
SC 13G/A Amended ownership over 5% (passive) Mar 7, 2023 —
SC 13G Ownership over 5% (passive) Feb 13, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
8-K Current report
Results of operations
Feb 8, 2023 Feb 8, 2023
10-Q Quarterly report Feb 8, 2023 Dec 31, 2022
3 Initial insider ownership Feb 8, 2023 Feb 6, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PAHC (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Teaneck, NJ
SEC filer status
Large accelerated filer
SEC CIK
1069899
Former names
PHILIPP BROTHERS CHEMICALS INC (until May 14, 2003)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.